Eat your vegetables, help your heart: How plant-based diets can boost cardiovascular health Two separate research teams have highlighted the benefits of limiting meat consumption and adopting a plant-based diet. Read more about Eat your vegetables, help your heart: How plant-based diets can boost cardiovascular health
Edwards Lifesciences, Abbott agree to end patent dispute In a statement announcing the news, Edwards said it “considers this agreement a positive development."Read more about Edwards Lifesciences, Abbott agree to end patent dispute
'A missed opportunity': Statin use low among patients with peripheral artery disease Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.Read more about 'A missed opportunity': Statin use low among patients with peripheral artery disease
SNMMI 2020: Imaging highlights connection between heart and kidneys in heart attack response Researchers monitored how the heart and kidneys responded one day, three days, seven days and six weeks following an induced myocardial infarction. Read more about SNMMI 2020: Imaging highlights connection between heart and kidneys in heart attack response
Medtronic’s new ICM gains FDA clearance, CE mark approval The device is roughly one-third the size of a AAA battery.Read more about Medtronic’s new ICM gains FDA clearance, CE mark approval
Breast cancer 60% more fatal for heart attack survivors The eye-opening study tracked more than 1,700 patients with early-stage breast cancer.Read more about Breast cancer 60% more fatal for heart attack survivors
COVID-related strokes carry a greater risk of disability, death When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.Read more about COVID-related strokes carry a greater risk of disability, death
Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition. Read more about Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease
Tim Attebery, former American College of Cardiology and MedAxiom CEO, named Vxtra Health board chair Attebery Back in April, Attebery announced his resignation from the ACC and MedAxiom.Read more about Tim Attebery, former American College of Cardiology and MedAxiom CEO, named Vxtra Health board chair
Outcomes ‘worse than expected’ when TAVR fails and surgery is required The mortality rate was 17% for patients undergoing SAVR following a failed TAVR. Read more about Outcomes ‘worse than expected’ when TAVR fails and surgery is required